CVS Health (NYSE:CVS – Get Free Report) and Biocorrx (OTCMKTS:BICX – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, risk, valuation, profitability and institutional ownership.
Volatility and Risk
CVS Health has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, Biocorrx has a beta of 0.07, indicating that its share price is 93% less volatile than the S&P 500.
Analyst Ratings
This is a summary of current ratings and recommmendations for CVS Health and Biocorrx, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| CVS Health | 0 | 4 | 21 | 2 | 2.93 |
| Biocorrx | 0 | 1 | 0 | 0 | 2.00 |
Profitability
This table compares CVS Health and Biocorrx’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| CVS Health | 0.12% | 11.45% | 3.40% |
| Biocorrx | N/A | N/A | -96.39% |
Earnings and Valuation
This table compares CVS Health and Biocorrx”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| CVS Health | $394.08 billion | 0.26 | $4.61 billion | $0.38 | 210.21 |
| Biocorrx | $10,000.00 | 781.77 | -$5.11 million | ($0.32) | -1.03 |
CVS Health has higher revenue and earnings than Biocorrx. Biocorrx is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
80.7% of CVS Health shares are held by institutional investors. 1.2% of CVS Health shares are held by insiders. Comparatively, 21.4% of Biocorrx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
CVS Health beats Biocorrx on 13 of the 15 factors compared between the two stocks.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
About Biocorrx
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
